Filing Details

Accession Number:
0001567619-22-003750
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-11 18:56:05
Reporting Period:
2022-02-09
Accepted Time:
2022-02-11 18:56:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921114 Armata Pharmaceuticals Inc. ARMP Biological Products, (No Disgnostic Substances) (2836) 911549568
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1080014 Innoviva, Inc. 1350 Old Bayshore Highway Suite 400
Burlingame CA 94010
Yes No Yes No
1842875 Innoviva Strategic Opportunities Llc 1350 Old Bayshore Highway Suite 400
Burlingame CA 94010
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-09 3,614,792 $5.00 10,980,761 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to Purchase Common Stock Acquisiton 2022-02-09 1,807,396 $5.00 1,807,396 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,807,396 2022-02-09 2027-02-09 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,710,800 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrants to Purchase Common Stock $3.25 0 6,153,847 Direct
Common Stock Warrants to Purchase Common Stock $2.87 0 8,710,800 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
0 6,153,847 Direct
0 8,710,800 Direct
Footnotes
  1. See Exhibit 99.1
  2. See Exhibit 99.1
  3. See Exhibit 99.1
  4. See Exhibit 99.1